CalciMedica Inc. (NASDAQ: CALC)
$2.8250
-0.0650 ( -2.25% ) 42.9K
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Market Data
Open
$2.8250
Previous close
$2.8900
Volume
42.9K
Market cap
$38.96M
Day range
$2.7450 - $3.0440
52 week range
$2.0500 - $8.3800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Mar 29, 2024 |
| 424b5 | Other | 2 | Mar 29, 2024 |
| 8-k | 8K-related | 13 | Mar 28, 2024 |
| 10-k | Annual reports | 117 | Mar 28, 2024 |
| s-8 | Registration statements | 5 | Mar 28, 2024 |
| 8-k | 8K-related | 46 | Feb 13, 2024 |
| effect | Other | 1 | Feb 09, 2024 |
| sc | Insider transactions | 1 | Feb 08, 2024 |
| sc | Insider transactions | 1 | Feb 08, 2024 |
| corresp | Comment letters | 1 | Feb 07, 2024 |